Injective (INJ) Rises Over 5% as Price Nears $6 Amid Volume Surge and Market Recovery

  • Injective’s price has risen more than 5% in the past 24 hours, reaching an intraday high of $5.85.
  • Bulls could aim for $10, but that depends on clearing the $6 resistance.
  • INJ is poised to benefit from broader market momentum and key network developments.

Injective’s native token was among the altcoins that posted gains on December 8, 2025, rising more than 5% to an intraday peak of $5.85 as investor attention shifts ahead of a pivotal week for risk assets.

The INJ price appeared to push toward $6, a level that earlier capped downside pressure on December 4.

Notably, Injective’s advance coincided with a notable uptick in trading activity.

Injective price climbs toward $6 amid rising volume

Injective’s price has been in a downtrend since its all-time high of $52.75 in March 2024. The token remains roughly 89% below that peak and has lost about 25% over the past month.

Recent market gains have, however, helped bulls regain footing, and INJ has recovered from support around $5.

At the time of writing, INJ traded near $5.71, up more than 5% over the previous 24 hours.

Bulls reached an intraday high of $5.85 as they pushed toward the psychological $6 mark. Trading volume also rose to $67 million, an increase of more than 52% in the last 24 hours.

Why has Injective’s price risen?

The token’s advance came alongside Bitcoin’s rally above $92,000 and Ethereum’s recovery above $3,100, contributing to broader market strength that appears to have lifted Injective.

Analysts also pointed to Injective’s recent integration with DexTools, which exposes the chain to 15 million users for real-time asset tracking.

Momentum from Helix, a major decentralized spot and derivatives exchange in the INJ ecosystem, appears to be another key driver.

Helix recently rolled out an upgrade enabling gas-free 24/7 trading of stocks, indices and cryptocurrencies, which has increased interest in the network.

🌐 Trade RWAs on @HelixMarkets

Stocks, pre-IPO markets, commodities, FX — all tradable on-chain.

📊 Live markets:
$AAPL, $NVDA, $AMZN, $SpaceX, $TSLA, Gold and more! pic.twitter.com/ErlY5ZVXd3

— Helix 🧬 (@HelixMarkets) December 5, 2025

Meanwhile, the community has reacted positively to a governance proposal approving an on-chain equity-pleasing mechanism.

Additionally, progress across stablecoin launches and real-world asset (RWA) initiatives has helped boost the token’s appeal.

INJ price outlook

Although the 24-hour high of $5.85 saw bulls test the $6 level, the technical picture remains mixed. The broader trend is still downward, and a resumption of that decline could spell trouble for buyers.

Injective Price Chart
Injective price chart from TradingView

The Relative Strength Index (RSI) sits at 44, below the neutral midpoint.

However, the RSI is tilting upward, suggesting a potential breakout. The Moving Average Convergence Divergence (MACD) also shows modest bullish momentum after a recent bullish crossover.

Going forward, INJ’s path hinges on either a bullish breakout or cautious consolidation.

In the near term, a breakout above $6 would open targets at $8.22 and then $10. Conversely, a drop below $5.05 could pose a significant risk to buyers.